Global mRNA Platform Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global mRNA Platform Market Research Report 2024
The mRNA platform refers to a technology and method used for vaccine development and gene therapy. mRNA, or messenger RNA, is a single-stranded molecule that carries genetic information from DNA to the ribosomes in cells, where it is translated into proteins. In the mRNA platform, synthetic mRNA molecules containing the genetic code for a specific protein are delivered into cells to instruct them to produce that protein.
According to Mr Accuracy reports new survey, global mRNA Platform market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole mRNA Platform market research.
Key companies engaged in the mRNA Platform industry include Arcturus Therapeutic, Argos Therapeutics, BioNTec, CureVac, Etherna, Ethris, GlaxoSmithKline, Pfizer and Translate Bio, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of mRNA Platform were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole mRNA Platform market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global mRNA Platform market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Arcturus Therapeutic
Argos Therapeutics
BioNTec
CureVac
Etherna
Ethris
GlaxoSmithKline
Pfizer
Translate Bio
Segment by Type
Infectious Disease Vaccines
Cancer Vaccines
Infectious Disease
Cancer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The mRNA Platform report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports new survey, global mRNA Platform market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole mRNA Platform market research.
Key companies engaged in the mRNA Platform industry include Arcturus Therapeutic, Argos Therapeutics, BioNTec, CureVac, Etherna, Ethris, GlaxoSmithKline, Pfizer and Translate Bio, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of mRNA Platform were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole mRNA Platform market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global mRNA Platform market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Arcturus Therapeutic
Argos Therapeutics
BioNTec
CureVac
Etherna
Ethris
GlaxoSmithKline
Pfizer
Translate Bio
Segment by Type
Infectious Disease Vaccines
Cancer Vaccines
Segment by Application
Infectious Disease
Cancer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The mRNA Platform report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source